MilliporeSigma
  • Home
  • Search Results
  • Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs.

Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs.

Journal of the American Veterinary Medical Association (2008-08-05)
Robert Six, Judy Cherni, Robert Chesebrough, Dawn Cleaver, Cindy J Lindeman, Georg Papp, Terry L Skogerboe, Daniel J Weigel, Joseph F Boucher, Michael R Stegemann
ABSTRACT

To evaluate the efficacy and safety of administration of cefovecin, compared with cefadroxil, for treatment of naturally occurring secondary superficial pyoderma, abscesses, and infected wounds in dogs. Multicenter, randomized, positive-controlled clinical trial. 235 client-owned dogs. Dogs with clinical signs of skin infection confirmed via bacteriologic culture were randomly allocated to receive a single SC injection of cefovecin (8 mg/kg [3.6 mg/lb]) followed by placebo administered PO twice daily for 14 days or cefadroxil (22 mg/kg [10 mg/lb]) administered PO twice daily for 14 days following a placebo injection. Two 14-day treatment courses were permitted. Treatment success was defined as reduction of clinical signs to mild or absent at the final assessment. Clinical efficacy achieved with cefovecin in dogs was equivalent to that observed with cefadroxil. At the final assessment, 14 days following the completion of treatment (on day 28 or 42), 92.4% (109/118) of the cefovecin group and 92.3% (108/117) of the cefadroxil group were treatment successes. There were no serious adverse events or deaths related to treatment. A single cefovecin injection (8 mg/kg) administered SC, which could be repeated once after 14 days, was safe and effective against naturally occurring skin infections in dogs and as effective as cefadroxil administered PO twice daily for 14 or 28 days.

MATERIALS
Product Number
Brand
Product Description

Supelco
Cefadroxil, analytical standard